EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Psa index psai as a predictor of prostate cancer cap in men with persistent serum psa elevation



Psa index psai as a predictor of prostate cancer cap in men with persistent serum psa elevation



Journal of Urology 147(4 SUPPL): 387A




(PDF emailed within 1 workday: $29.90)

Accession: 033019076

Download citation: RISBibTeXText



Related references

Serum psa index psai as a staging tool for patients with otherwise clinically localized prostate cancer cap. Journal of Urology 147(4 SUPPL): 292A, 1992

Selection of patients with prostate cancer cap for laparoscopic lymph node dissection use of serum psa and psa index psai. Journal of Urology 147(4 SUPPL): 245A, 1992

Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia. Prostate 70(16): 1788-1798, 2010

Resistive index of prostatic capsular arteries as a predictor of prostate cancer in patients undergoing initial prostate biopsy. Medical Oncology 31(12): 297-297, 2015

The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index-which is the best predictor of prostate cancer after a negative biopsy?. Journal of Urology 192(1): 60-66, 2015

Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World Journal of Surgery 35(5): 1017-1025, 2011

Serum BPSA is a better predictor of prostate enlargement than either total PSA or free PSA in men without prostate cancer. Journal of Urology 171(4 Supplement): 403, April, 2004

The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. Kaohsiung Journal of Medical Sciences 28(12): 649-653, 2013

Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. Bju International 105(4): 481-484, 2010

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower. Cancer 113(10): 2695-2703, 2008

Value of the serum prostate-specific antigen-alpha1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer. BJU International 88(1): 53-57, July, 2001

Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Cancer Investigation 13(1): 31-35, 1995

Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer. Clinical Chemistry 59(1): 280-288, 2013

Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer. Seminars in Urologic Oncology 18(2): 160-165, 2000